201 related articles for article (PubMed ID: 21109936)
1. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.
Kaenel P; Schwab C; Mülchi K; Wotzkow C; Andres AC
Int J Oncol; 2011 Jan; 38(1):151-60. PubMed ID: 21109936
[TBL] [Abstract][Full Text] [Related]
2. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.
Kaenel P; Antonijevic M; Richter S; Küchler S; Sutter N; Wotzkow C; Strange R; Andres AC
Int J Oncol; 2012 Feb; 40(2):357-69. PubMed ID: 22020958
[TBL] [Abstract][Full Text] [Related]
3. Deregulated ephrin-B2 expression in the mammary gland interferes with the development of both the glandular epithelium and vasculature and promotes metastasis formation.
Haldimann M; Custer D; Munarini N; Stirnimann C; Zürcher G; Rohrbach V; Djonov V; Ziemiecki A; Andres AC
Int J Oncol; 2009 Sep; 35(3):525-36. PubMed ID: 19639173
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
5. Mammary epithelial-specific knockout of the ephrin-B2 gene leads to precocious epithelial cell death at lactation.
Weiler S; Rohrbach V; Pulvirenti T; Adams R; Ziemiecki A; Andres AC
Dev Growth Differ; 2009 Dec; 51(9):809-19. PubMed ID: 19843150
[TBL] [Abstract][Full Text] [Related]
6. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
7. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
8. A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis.
Suenobu S; Takakura N; Inada T; Yamada Y; Yuasa H; Zhang XQ; Sakano S; Oike Y; Suda T
Biochem Biophys Res Commun; 2002 May; 293(3):1124-31. PubMed ID: 12051776
[TBL] [Abstract][Full Text] [Related]
9. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
10. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
11. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
12. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization.
Kaenel P; Hahnewald S; Wotzkow C; Strange R; Andres AC
Dev Growth Differ; 2014 May; 56(4):255-75. PubMed ID: 24635767
[TBL] [Abstract][Full Text] [Related]
14. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population.
Pratt MA; Tibbo E; Robertson SJ; Jansson D; Hurst K; Perez-Iratxeta C; Lau R; Niu MY
Oncogene; 2009 Jul; 28(30):2710-22. PubMed ID: 19483731
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
16. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
18. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.
Wang Y; Menendez A; Fong C; ElAlieh HZ; Chang W; Bikle DD
J Bone Miner Res; 2014 Aug; 29(8):1900-13. PubMed ID: 24677183
[TBL] [Abstract][Full Text] [Related]
19. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis.
Nikolova Z; Djonov V; Zuercher G; Andres AC; Ziemiecki A
J Cell Sci; 1998 Sep; 111 ( Pt 18)():2741-51. PubMed ID: 9718367
[TBL] [Abstract][Full Text] [Related]
20. Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells.
Meyer S; Hafner C; Guba M; Flegel S; Geissler EK; Becker B; Koehl GE; Orsó E; Landthaler M; Vogt T
Int J Oncol; 2005 Nov; 27(5):1197-206. PubMed ID: 16211213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
